Lexington OTC Stock Today

LXGTF -  USA Stock  

USD 0.03  0.002  6.25%

Lexington Biosciences is trading at 0.03 as of the 25th of July 2021, a -6.25 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.03. Lexington Biosciences has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Lexington Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of April 2021 and ending today, the 25th of July 2021. Click here to learn more.
 Market Performance
6 of 100
  Odds Of Distress
Less than 26
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Lexington Biosciences OTC Stock Profile

Registered Plan Private Investments Inc. operates as a private investment platform company. Registered Plan Private Investments Inc. was incorporated in 2016 and is headquartered in Vancouver, Canada. Lexington Biosciences is traded on OTC Exchange in the United States. more on Lexington Biosciences
Lexington Biosciences is way too risky over 90 days horizon
Lexington Biosciences has some characteristics of a very speculative penny stock
Lexington Biosciences appears to be risky and price may revert if volatility continues
The company has accumulated 3.23 K in total debt with debt to equity ratio (D/E) of 4.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Lexington Biosciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Net Loss for the year was (422.35 K).
Lexington Biosciences has accumulated about 9.8 K in cash with (311.39 K) of positive cash flow from operations.
Legal NameLexington Biosciences
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Lexington Biosciences' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellFairly Valued
Lexington Biosciences [LXGTF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 113.61 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lexington Biosciences's market, we take the total number of its shares issued and multiply it by Lexington Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Lexington Biosciences classifies itself under Healthcare sector and is part of Medical Devices industry. The entity has 3.79 M outstanding shares. Lexington Biosciences has accumulated about 9.8 K in cash with (311.39 K) of positive cash flow from operations.
Check Lexington Biosciences Probability Of Bankruptcy

Lexington Stock Price Odds Analysis

What are Lexington Biosciences' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Lexington Biosciences jumping above the current price in 90 days from now is about 91.82%. The Lexington Biosciences probability density function shows the probability of Lexington Biosciences otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Lexington Biosciences has a beta of -5.7733. This indicates as returns on its benchmark rise, returns on holding Lexington Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Lexington Biosciences is expected to outperform its benchmark. In addition to that, the company has an alpha of 2.7704, implying that it can generate a 2.77 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 0.03HorizonTargetOdds Up 0.03 
8.15%90 days
 0.03 
91.82%
Based on a normal probability distribution, the odds of Lexington Biosciences to move above the current price in 90 days from now is about 91.82 (This Lexington Biosciences probability density function shows the probability of Lexington OTC Stock to fall within a particular range of prices over 90 days) .

Lexington Biosciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lexington Biosciences market risk premium is the additional return an investor will receive from holding Lexington Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lexington Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lexington Biosciences' alpha and beta are two of the key measurements used to evaluate Lexington Biosciences' performance over the market, the standard measures of volatility play an important role as well.

Lexington Stock Against Markets

Picking the right benchmark for Lexington Biosciences otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lexington Biosciences otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lexington Biosciences is critical whether you are bullish or bearish towards Lexington Biosciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lexington Biosciences without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Additionally, see Stocks Correlation. Note that the Lexington Biosciences information on this page should be used as a complementary analysis to other Lexington Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Lexington OTC Stock analysis

When running Lexington Biosciences price analysis, check to measure Lexington Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexington Biosciences is operating at the current time. Most of Lexington Biosciences' value examination focuses on studying past and present price action to predict the probability of Lexington Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexington Biosciences' price. Additionally, you may evaluate how the addition of Lexington Biosciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
The market value of Lexington Biosciences is measured differently than its book value, which is the value of Lexington that is recorded on the company's balance sheet. Investors also form their own opinion of Lexington Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Lexington Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexington Biosciences' market value can be influenced by many factors that don't directly affect Lexington Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexington Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Lexington Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexington Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.